Log in to save to my catalogue

Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmo...

Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3976535

Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease

About this item

Full title

Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease

Publisher

England: BioMed Central Ltd

Journal title

Respiratory research, 2014-04, Vol.15 (1), p.37-37

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Oral corticosteroids were used to control stable chronic obstructive pulmonary disease (COPD) decades ago. However, recent guidelines do not recommend long-term oral corticosteroids (LTOC) use for stable COPD patients, partly because it causes side-effects such as respiratory muscle deterioration and immunosuppression. Nonetheless, the impact of LT...

Alternative Titles

Full title

Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3976535

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3976535

Other Identifiers

ISSN

1465-9921,1465-993X

E-ISSN

1465-993X,1465-9921

DOI

10.1186/1465-9921-15-37

How to access this item